31 Mar 2023
Assets2,014.46
Total Income1,133.99
EBITDA446.05
Profit After Tax385.19
NET Worth1,740.67
Reserves and Surplus1,628.88
Total Borrowing125.06
Open · Close · Listing
Anthem Biosciences is a Mainboard IPO with an issue size of ₹3,395.00 crore, proposed for listing on BSE, NSE. The issue structure includes an offer-for-sale component of ₹3,395.00 crore.
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 20.82% |
| ROCE | 26.88% |
| Debt / Equity | 0.05% |
| RoNW | 20.82% |
| PAT Margin | 23.38% |
| EBITDA Margin | 36.81% |
| Price to Book Value | 13.23 |
| Expense | Amount |
|---|---|
| Fees and commissions payable to the BRLMs (including any underwriting commission, brokerage and selling commission) | ₹81.30 Cr |
| Advertising and marketing expenses | ₹9.38 Cr |
| Fees payable to the Registrar to the Offer | ₹9.42 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Offer. Brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹8.26 Cr |
| Printing and distribution of Offer stationery | ₹1.62 Cr |
| Regulatory filing fees, book building software fees, listing fees etc. | ₹4.15 Cr |
| Fee payable to statutory auditor, namely K.P. Rao & Co., Chartered Accountants | ₹0.53 Cr |
| Fees payable to other intermediaries | ₹2.23 Cr |
| Fee payable to legal counsels | ₹9.80 Cr |
| Miscellaneous | ₹1.18 Cr |